Data analysis of implementability of Pharmacogenomics guided dose modifications in eight African countries

Data for analysis of implementability of Pharmacogenomics in 8 African countries with ML# rated National Regulatory Authorities- based on registered drug formulation/strength availability as of 1 June 2025. These countries include Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania, and Zimbabwe.本数据集用于分析8个拥有ML#评级国家药品监管机构的非洲国家的药物基因组学（Pharmacogenomics）可实施性，分析依据为截至2025年6月1日的已注册药物制剂/规格可用性情况。涉及国家包括埃及、加纳、尼日利亚、卢旺达、塞内加尔、南非、坦桑尼亚及津巴布韦。